|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from (used in) operating activities [abstract] | |||||
| Net income | |||||
| Adjustments for the following items: | |||||
| Depreciation | |||||
| Finance costs (note 14) | |||||
| Impairment charges (reversals) (notes 10 and 21) | |||||
| Income tax expense (note 12) | |||||
| Income from equity investees (note 16) | |||||
| Loss on currency translation | |||||
| Net expense for business combination | |||||
| Gain on sale of non-current assets (note 9) | |||||
| Change in working capital (note 15) | |||||
| Other operating activities (note 15) | |||||
| Operating cash flows before interest and income taxes | |||||
| Interest paid | |||||
| Interest received | |||||
| Income taxes paid | |||||
| Net cash provided by operating activities | |||||
| Cash flows from (used in) investing activities [abstract] | |||||
| Capital expenditures (note 5) | |||||
| Sales proceeds | |||||
| Proceeds from divestitures | |||||
| Income taxes paid (refund), classified as investing activities | |||||
| Proceeds from sales of investments other than investments accounted for using equity method | |||||
| Purchase of investments other than investments accounted for using equity method | |||||
| Cash advances and loans made to other parties, classified as investing activities | |||||
| Dividends received from investments accounted for using equity method, classified as investing activities | |||||
| Cash receipts from repayment of advances and loans made to other parties | |||||
| Cash flows from (used in) investing activities | |||||
| Cash flows from (used in) financing activities [abstract] | |||||
| Lease repayments | |||||
| Debt repayments | |||||
| Dividends (note 31) | |||||
| Share buyback program (note 31) | |||||
| Funding from non-controlling interests (note 32) | |||||
| Disbursements to non-controlling interests (note 32) | |||||
| Other financing activities (note 15) | |||||
| Proceeds from issue of bonds, notes and debentures | |||||
| Cash flows from (used in) financing activities | |||||
| Effect of exchange rate changes on cash and equivalents | |||||
| Net increase (decrease) in cash and equivalents | |||||
| Cash and equivalents at beginning of year (note 25a) | |||||
| Cash and equivalents at end of year | |||||
Loading...
